Impact
The 20th ILCA Annual Conference serves as a premier global stage where breakthrough
science meets clinical practice. The vital support of our industry partners is what drives this
ecosystem forward, enabling cross-border collaborations that ultimately transform patient
outcomes in hepatology and oncology.
By partnering with ILCA, these organizations demonstrate a shared commitment to fostering
multidisciplinary dialogue and accelerating the translation of research into real-world medical
solutions.
ILCA Annual Conference
We are grateful to our three Principal Sponsors:
*The ILCA scientific programme is curated with strict independence by the governing committees and remains entirely free from any external commercial or funding influence.
The Value of an ILCA Partnership
Drive Field-Wide Innovation
Position your organization at the forefront of hepatobiliary oncology by supporting educational initiatives that redefine how liver cancer is prevented and managed globally.
Engage with Key Decision-Makers
Connect directly with leading clinician-scientists, international researchers, and multidisciplinary healthcare pioneers, cultivating relationships that extend far beyond the conference.
Contribute to the Scientific Dialogue
Present your organization’s perspective, share insights on clinical developments, and participate actively in an international forum dedicated to academic excellence.
Strengthen Global Health Networks
Support a highly specialized, unified community that bridges the gap between laboratory research and bedside patient care across multiple continents.
Become a Partner for ILCA 2026
Interested in learning how your organization can collaborate with us this September in Brussels? Reach out to our team to discover tailored sponsorship opportunities.
Discover
[Contact Form]
Sponsorship Opportunities
Please, do no to hesitate to contact us to find out more about sponsorship opportunities.
